19Dec
As its COVID-19 Vaccine Nears Finalization, AstraZeneca Announces Deal to Buy Alexion for $39 Billion
AstraZeneca, the British-Swedish multinational pharmaceutical company currently collaborating with the University of Oxford on a COVID-19 vaccine, will purchase Alexion Pharmaceuticals for $39 billion. The transaction, which awaits approval by shareholders and regulators, is the largest purchase by a health care company this year and is expected to close in the third quarter of 2021. Alexion was founded in 1992 and is headquartered in Boston but has a global presence. It is known for its...
By:
Rothwell, Figg, Ernst & Manbeck, P.C.
Related
New York City’s Fair Workweek Law survived a challenge on Feb. 13 when Justice Arthur Engoron of th...
Read More >
Important deadlines concerning the new Massachusetts Paid Family and Medical Leave (PFML) law are ap...
Read More >
The U.S. Court of Appeals for the Third Circuit has lifted a prior injunction on Philadelphia's sala...
Read More >
Sixty former workers of Load Trail, a leading trailer manufacturing business, have filed a class-act...
Read More >
The U.S. Court of Appeals for the Third Circuit recently issued a decision that could change the lia...
Read More >
With coronavirus interrupting the construction industry, Akerman attorneys offer guidance on how to ...
Read More >